This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Celanese Hikes Acetyl Intermediates & Acetone Products Prices
by Zacks Equity Research
Celanese's (CE) latest price increase is applicable for orders shipped and is immediately effective or as contracts permit.
Here's Why You Should Hold Onto Celanese (CE) Stock for Now
by Zacks Equity Research
Celanese (CE) gains on productivity improvement actions amid a sluggish demand environment.
Celanese (CE) Stock Up 16% in 3 Months: What's Driving It?
by Zacks Equity Research
Celanese (CE) benefits from its productivity improvement actions and strategic acquisitions.
Celanese (CE) Raises Prices of Acetyl Intermediate Products
by Zacks Equity Research
Celanese's (CE) latest price increase is applicable for orders shipped and is immediately effective or as contracts permit.
Celanese's (CE) Earnings and Sales Surpass Estimates in Q2
by Zacks Equity Research
Celanese's (CE) Acetyl Chain unit sales hurt by persistent decline in industry pricing due to deflationary environment for raw materials.
Celanese (CE) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of 19.27% and 11.11%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Celanese (CE) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Soft demand conditions due to coronavirus are likely to have weighed on Celanese's (CE) second-quarter performance.
Celanese (CE) to Divest Stake in Polyplastics JV to Daicel
by Zacks Equity Research
Celanese (CE) plans to use the proceeds from the all-cash transaction in value-generating opportunities.
Earnings Preview: Celanese (CE) Q2 Earnings Expected to Decline
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Keep Celanese (CE) in Your Portfolio
by Zacks Equity Research
Celanese (CE) benefits from productivity and operational improvement actions as well as strategic acquisitions.
Chemical Specialty Industry Outlook Bleak on Muted Demand
by Anindya Barman
Weak demand and raw material supply disruptions due to coronavirus pose as headwinds to the chemical specialty industry.
Celanese Increases Prices of Acetyl Intermediate Products
by Zacks Equity Research
Celanese's (CE) latest price increase is incremental to any previously announced hikes.
Linde (LIN) Commences Operations in New Plants in Texas
by Zacks Equity Research
Linde's (LIN) new facilities are likely to supply oxygen, nitrogen and carbon monoxide to global technology and specialty materials company, Celanese.
5 Battered Stocks to Keep on Radar Amid Coronavirus Sell-Off
by Aniruddha Ganguly
Here we discuss five stocks, which have lost significant worth so far this year but show great potential to bounce back.
Here's Why You Should Buy Celanese (CE) Stock Right Now
by Zacks Equity Research
Celanese (CE) is well placed for growth on the back of its inorganic growth actions and project investments.
CE or ECL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CE vs. ECL: Which Stock Is the Better Value Option?
US Chemicals Set for a Slump in 2020 on Coronavirus-Led Slowdown
by Anindya Barman
Amid softness across major end-use and export markets, the ACC envisions U.S. chemical volumes to tumble 9.3% in 2020.
Celanese (CE) Extends Long-Term Feedstock Contract In China
by Zacks Equity Research
Per Celanese (CE), the latest deal will provide its Nanjing facility with a reliable supply of carbon monoxide for its 1,200-kiloton acetic acid plant.
Celanese (CE) Set to Increase Prices of Vinyl Acetate Monomer
by Zacks Equity Research
Celanese's (CE) latest price increase is incremental to any previously announced hikes.
Here's Why You Should Hold Onto Celanese (CE) Stock Now
by Anindya Barman
Celanese (CE) gains from productivity and operational improvement actions as well as strategic acquisitions.
Celanese (CE) Inks Technology Licensing Agreement in China
by Zacks Equity Research
Celanese's (CE) latest agreement marks the expansion of the cooperation into value chain of the acetyls industry.
Celanese (CE) Up 11.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celanese Increases Price of Acetyl Intermediates in China
by Zacks Equity Research
Celanese's (CE) latest price increase is incremental to any previously announced hikes.
New Strong Sell Stocks for May 20th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Celanese (CE) Inks MoU to Supply Ethylene-Based VAM to Wanwei
by Zacks Equity Research
Celanese (CE) plans to supply VAM to Wanwei from its world-scale chemical industrial facility in China.